The B2B Podcast Index
Index
All categories
MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
MethodologySubmit
Best of:MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
An independent project byFame
SearchBest episodesGuestsInsightsMethodologySubmit a podcast
#2357Venture Pill65.0 / 100Get badge
← The Index
Venture Pill artwork
Startups & FoundersNEW this period

Venture Pill

Hosted by Sam Gordon

Your weekly dose of startups and venture capital. Brandon Osian and Sam Gordon prescribe all you'll need to get into the wonderful world of venture. From fundraising news to startup deep dives, you can expect to stay up to date with the most innovative, exciting companies out there.

150 episodes · publishes weekly · latest 2025-07-31 · ~30 min/episode

Rank

#2357

Substance

65.0

/ 100

Breakdown

Scored 2026-07
Updated monthly

Startups & Founders rank

#363 of 923

Best B2B Startups & Founders Podcasts →

Across the index

#2357 of 6183

Substance

Top 38%

outscores 62% of the index

Why it scores where it does

Venture Pill ranks #2357 on The B2B Podcast Index with a substance score of 65.0 out of 100, scored across 1 recent episode. It scores highest on guest caliber and specificity & evidence. Collins is a genuine practitioner who built a real firm to $1.5B raised and 11,000 customers starting from zero, with early career roots at TA Associates in 1986 and a meaningful HBS network; credible and relevant, but not a top-tier name and the transcript doesn't extract deep hard-won operational insight commensurate with his experience.

The five-dimension breakdown

Averaged across 1 recently scored episode, with cited evidence.

Insight Density

13.0 / 20

The episode mixes some genuine operational nuggets (AI rollup thesis, T-shaped investor development, the 'special assistant' hiring model) with large stretches of VC 101 basics like power law and J-curve explanation pitched at novices, plus biographical filler and motivational platitudes that add little for a B2B operator.

“we love um, the idea of AI roll ups, meaning taking an industry that has maybe been around a while, that's maybe pretty fragmented, you know, bringing AI to it and then um, kind of adopting the PE playbook of kind of buy, merge, consolidate”

“the replacement value of one VC over another is not that great. It's a little overstated”

Originality

12.0 / 20

There are a handful of mildly contrarian angles - questioning VC board value, the 'network as asset' framing, hiring recent grads as AI-native 'special assistants' - but the episode leans heavily on well-worn VC tropes and the explicit 'contrarian take' segment produces nothing contrarian at all, which goes unchallenged.

“the replacement value of one VC over another is not that great”

“the young person right out of college, what an amazing opportunity to learn from an experienced chief marketing officer. And then the chief marketing officer gets the value of AI. And, um, it's kind of one plus one equals ten”

Guest Caliber

16.0 / 20

Collins is a genuine practitioner who built a real firm to $1.5B raised and 11,000 customers starting from zero, with early career roots at TA Associates in 1986 and a meaningful HBS network; credible and relevant, but not a top-tier name and the transcript doesn't extract deep hard-won operational insight commensurate with his experience.

“my first job after college was at a venture capital firm. Um, this is way back 1986 with a firm called TA Associates”

“we've raised about a billion five. We have, you know, 11,000 customers”

Specificity & Evidence

15.0 / 20

The episode includes a reasonable layer of concrete numbers - AV's AUM, customer count, team structure, recommended portfolio sizes - and some useful market comparisons, but it is thin on portfolio company names, actual fund return data, or deal-level specifics that would let an operator stress-test the claims.

“we've raised about a billion five. We have, you know, 11,000 customers”

“companies would go public at a 300, 500 million dollar valuation. And now companies are raising 15 billion at a, you know, 100 billion pre privately”

Conversational Craft

9.0 / 20

The hosts have an overt conflict of interest (one is an AV employee, one a former AV fellow, disclosed upfront), ask exclusively softballs with no meaningful follow-up, and never challenge a single claim - including letting a non-contrarian answer to the 'contrarian take' question pass entirely without pushback.

“As an AV employee. And with Sam having been a Venture Fellow back in the day, this conversation was especially meaningful to us”

“What's uh, one contrarian take that you have?”

Standout episodes

  • E149: Interview with Mike Collins, CEO of Alumni Ventures

    2025-07-31

    65

Rank over time

First period on the Index - history builds from here.

Episodes

1 scored on substance · 60 tracked in total.

  • E149: Interview with Mike Collins, CEO of Alumni Ventures

    2025-07-31 · 52 min

    65 / 100

Frequently asked

What is Venture Pill's substance score?
Venture Pill scores 65.0 out of 100 for substance and ranks #2357 on The B2B Podcast Index. That puts it ahead of 62% of the B2B podcasts we rank and #363 of 923 in Startups & Founders. The score reflects insight density, originality, guest caliber, specificity and conversational craft across recent episodes - not downloads.
Is Venture Pill worth listening to?
Yes - Venture Pill outscores 62% of the B2B startups & founders podcasts and shows we rank on substance, so a startups & founders operator is likely to come away with something useful.
Who hosts Venture Pill?
Venture Pill is hosted by Sam Gordon.
How often does Venture Pill publish?
Venture Pill publishes weekly, has 150 episodes, released its most recent episode on 2025-07-31.
Which Venture Pill episode should I start with?
Our highest-scoring recent episode is "E149: Interview with Mike Collins, CEO of Alumni Ventures" (65/100) - a good place to start.

Show off your #363 rank in Startups & Founders

Add this badge to your site - it links back here and updates automatically as you rank.

Ranked #363 on The B2B Podcast Index
Embed code
<a href="https://index.fame.so/show/venture-pill" target="_blank" rel="noopener">
  <img src="https://index.fame.so/badge/venture-pill/badge.svg" alt="Ranked #363 on The B2B Podcast Index" width="360" height="136" />
</a>
Markdown & other formats →

Track Venture Pill's rank

Get an email whenever this show moves up or down the Index. Monthly at most, no spam.

Listen / subscribe:WebsiteRSS

Guests who've appeared

Mike Collins

Topics this show covers

The themes that come up most across this show's episodes.

SequoiaGLP-1 drugsPower law returnsJOBS Acta16zCo-investment modelAlumni VenturesJ-curveFintech venture capitalAI rollups

More Startups & Founders podcasts

See all →
  • eComFuel Podcast

    Andrew Youderian | e-Commerce Entrepreneur

    90.0
  • Inevitable

    an MCJ podcast

    90.0
  • Craig Swanson Guest Appearances

    Craig Swanson

    87.0
  • Vested Capital

    Yaro Starak

    87.0
  • Startup Stories - Mixergy

    Andrew Warner

    86.0
  • Invested by Aleph

    Michael Eisenberg

    86.0

Similar shows

Podcasts that dig into the same topics.

  • Venture Passport

    Richard Armstrong, Jack Richardson

    76.6
  • The Venture Capital Podcast with Fexingo

    Fexingo

    72.0
  • Making Billions

    Ryan Miller

    71.6
  • Ignite

    Ignite Insights

    81.0
  • The Puck: Venture Capital and Beyond

    Jim Baer

    81.0
  • CareTalk: Healthcare. Unfiltered.

    CareTalk: Healthcare. Unfiltered.

    80.8